论文部分内容阅读
目的探讨厄贝沙坦联合氨氯地平治疗老年2型糖尿病合并高血压的临床疗效。方法 128例老年2型糖尿病合并高血压患者,采用随机数字表法分为观察组和对照组,各64例。对照组给予厄贝沙坦口服治疗,观察组给予厄贝沙坦联合氨氯地平口服治疗,比较两组患者疗效。结果观察组总有效率为95.31%,明显高于对照组的84.38%(P<0.05);观察组组空腹血糖(FBG)收缩压(SBP)、舒张压(DBP)水平明显低于对照组(P<0.05)。结论厄贝沙坦联合氨氯地平有助于控制老年2型糖尿病合并高血压患者血糖、血压水平,改善血管舒缩功能障碍,保护肾功能,提高治疗效果。
Objective To investigate the clinical efficacy of irbesartan and amlodipine in the treatment of elderly type 2 diabetes with hypertension. Methods One hundred and eighty elderly patients with type 2 diabetes mellitus complicated with hypertension were divided into observation group and control group by random number table, each with 64 cases. The control group was given irbesartan oral treatment, the observation group was given irbesartan combined with amlodipine oral treatment, the efficacy of the two groups were compared. Results The total effective rate in the observation group was 95.31%, which was significantly higher than that in the control group (84.38%, P <0.05). The FBG systolic blood pressure (SBP) and diastolic blood pressure (DBP) in the observation group were significantly lower than those in the control group P <0.05). Conclusion Irbesartan combined with amlodipine helps to control the blood sugar and blood pressure, improve the vasomotor dysfunction, protect the renal function and improve the therapeutic effects in elderly type 2 diabetic patients with hypertension.